Commercial biotechnology: an international analysis
Congress of the U.S., Office of Technology Assessement, 1984 - Biology, Experimental - 612 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
62 other sections not shown
Other editions - View all
agreements agriculture amino acids animal antigen applications of biotechnology applied research areas bacteria basic research Biogen biological biotech biotechnology biotechnology R&D cells Cetus clinical cloned Commercializing Biotechnology competitive contract Corp costs countries culture diagnostic disease drugs enzymes established companies established U.S. companies factors Federal Republic firms foreign France funding gene Genentech genetic manipulation Genex growth guidelines Health Hoffmann-La Roche human hybridoma Hybritech important industry Institute insulin interferon investments Japan Japanese companies joint ventures Laboratories licensing MAbs manufacture ment micro-organisms microbial million molecular molecules Monoclonal Antibodies National NBFs nology Office of Technology organisms panies patent percent pharmaceutical plant plasmids potential protection protein rDNA rDNA research rDNA technology Recombinant DNA regulation Republic of Germany Science sector semiconductor specialty chemicals specific Switzerland synthesis tech Technology Assessment tion trade U.S. Congress U.S. Department U.S. Government United Kingdom University vaccines venture capital